context, we have developed a cell therapy medicinal product based on our expertise in tissue engineering and in the manipulation of pluripotent stem cells. This novel tissue engineered product
attractive technique by which we can produce fibrous biodegradable polymeric scaffolds for tissue engineering (TE) applications. Polyvinyl alcohol (PVA) is a biodegradable, biocompatible polymer with a fast-hydrolytic…
effects of adipose-derived mesenchymal stem cells (AD-MSC) on the formation of tissue-engineered vascular graft (TEVG). Materials & Methods: Tubular scaffolds 1.1 mm inner diameter were obtained ... observed by…
Background: Tissue engineering and cell therapy is a new perspective method for recovery of function and the formation of new centers of regeneration of damaged organs ... treatment of chronic liver failure (CLF) by…
important role in degrading aggrecan. To further explore the potential of Lentivirus in cartilage tissue engineering, the aggrecanases inhibited chondrocytes by Lentivector-mediated RNAi were seeded into scaffolds for…
Examples of highly porous scaffolds produced by direct digital manaufacturing for use in tissue engineering [5]. Recent Publications 1. Paula Pascoal-Faria, Pedro Castelo Ferreira, Abhishek Datta and Nuno Alves…
wound therapies are limited, so the search to develop better therapeutic strategies is ongoing. Tissue engineering and regenerative medicine (TERM) has caused a revolution in present and future trends ... with…
rejuvenation, regeneration or replacement. The current treatment approach includes transplantation of the kidney, tissue engineering cell therapy and gene therapy. In cell based therapy the exogenous material is used…
linking). Cutaneous injuries also have a high prevalence due to rising co-morbidities. The tissue engineering field has also developed in response to the shortcomings related to the tissue replacement
translational research into human patients. The talk aims to highlight these by addressing tissue-engineering (TE) approaches for the cornea and retina. New cell-based therapies are emerging to repair
translational research into human patients. The talk aims to highlight these by addressing tissue-engineering (TE) approaches for the cornea and retina. New cell-based therapies are emerging to repair
though there were no statistically significant differences, the lowest values were observed with the tissue engineered substitute. Therefore, it can be concluded that in vivo studies showed the potential